NEON THERAPEUTICS INC's ticker is NTGN and the CUSIP is 64050Y100. A total of 46 filers reported holding NEON THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $1,893,000 | -26.6% | 399,308 | 0.0% | 0.06% | -44.4% |
Q1 2019 | $2,580,000 | +28.4% | 399,308 | 0.0% | 0.11% | -28.0% |
Q4 2018 | $2,009,000 | -67.0% | 399,308 | -43.9% | 0.15% | -7.4% |
Q3 2018 | $6,079,000 | -32.2% | 711,808 | -0.0% | 0.16% | +5.9% |
Q2 2018 | $8,969,000 | – | 711,809 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 9,741,636 | $16,756,000 | 9.49% |
MYDA Advisors LLC | 155,000 | $267,000 | 0.12% |
Endurant Capital Management LP | 193,052 | $332,000 | 0.12% |
FNY Investment Advisers, LLC | 210,000 | $361,000 | 0.11% |
HARVARD MANAGEMENT CO INC | 505,871 | $870,000 | 0.08% |
Alambic Investment Management, L.P. | 25,800 | $44,000 | 0.03% |
OXFORD ASSET MANAGEMENT LLP | 209,307 | $360,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 155,619 | $268,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 116,600 | $201,000 | 0.00% |
Tower Research Capital LLC (TRC) | 14,371 | $25,000 | 0.00% |